公开(公告)号：EP2117455A2

公开(公告)日：2009-11-18

申请号：EP08725388.6

申请日：2008-02-08

申请人： Krueger, John, A. ,  Linderman, Evan, D.

发明人： Krueger, John, A. ,  Linderman, Evan, D.

IPC分类号： A61B17/88 ,  A61B17/34

CPC分类号： A61B17/8819 ,  A61B17/1604 ,  A61B17/1671 ,  A61B17/3421 ,  A61B17/3472 ,  A61B17/8811 ,  A61B2017/00331 ,  A61B2017/00455 ,  A61B2017/00867 ,  A61B2090/062

摘要： A curable material delivery cannula device (25) is disclosed. The device includes a cannula and a hub. The cannula includes an open proximal end, a deflectable segment (88) forming a pre-set curve, a lumen, and side orifice (s) (84) adjacent, and proximally spaced from, the distal end and fluidly connected to the lumen. When inserted within a guide cannula, the deflectable segment straightens. When distally extended from the guide cannula, the deflectable segment reverts to the curved shape. The distal end has a blunt tip for non-traumatic interface with bodily material. During use, curable material, such as bone cement, is delivered from the side orifice (s) in a radial direction relative to the lumen.

公开(公告)号：EP2771054A1

公开(公告)日：2014-09-03

申请号：EP12784117.9

申请日：2012-10-11

申请人： CareFusion 2200 Inc. ,  Looper, Anthony, M. ,  Landsman, Kelly ,  Krueger, John, A.

发明人： LOOPER, Anthony, M. ,  LANDSMAN, Kelly ,  KRUEGER, John, A.

IPC分类号： A61M25/00

CPC分类号： A61M25/0068 ,  A61M25/0009 ,  A61M31/00 ,  A61M2025/0018 ,  A61M2025/0057 ,  A61M2025/006

摘要： System and components for inducing pleurodesis while minimizing likelihood of tissue damage from direct application of pleurodesisenhancing materials. A tube device is provided that is configured to elute pleurodesis-enhancing material. The device includes one or more features configured to prevent or lessen the likelihood that the pleurodesisenhancing material comes into direct and concentrated contact with patient tissue when a distal length of the device is disposed indwelling a patient.

摘要翻译： 用于诱导胸膜固定术的系统和组件，同时最大限度地减少直接应用胸膜固定术增强材料引起的组织损伤的可能性。 提供一种配置成洗脱胸膜固定术增强材料的管装置。 该装置包括一个或多个特征，该特征被配置成当装置的远端长度留置于患者时防止或减少胸膜增强材料增强材料与患者组织直接和集中接触的可能性。